tiprankstipranks
Akoya Biosciences, NeraCare enter exclusive global license agreement
PremiumThe FlyAkoya Biosciences, NeraCare enter exclusive global license agreement
2M ago
Akoya Biosciences price target lowered to $3 from $4 at Piper Sandler
Premium
The Fly
Akoya Biosciences price target lowered to $3 from $4 at Piper Sandler
3M ago
Morgan Stanley, Comerica upgraded: Wall Street’s top analyst calls
Premium
The Fly
Morgan Stanley, Comerica upgraded: Wall Street’s top analyst calls
3M ago
Akoya Biosciences reports Q3 EPS (21c), consensus (20c)
PremiumThe FlyAkoya Biosciences reports Q3 EPS (21c), consensus (20c)
3M ago
Akoya Biosciences lowers FY24 revenue view to $80M-$85M, consensus $98.19M
Premium
The Fly
Akoya Biosciences lowers FY24 revenue view to $80M-$85M, consensus $98.19M
3M ago
AKYA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
AKYA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
Akoya Biosciences downgraded to Equal Weight from Overweight at Morgan Stanley
PremiumThe FlyAkoya Biosciences downgraded to Equal Weight from Overweight at Morgan Stanley
7M ago
Akoya Biosciences price target lowered to $7 from $7.50 at Craig-Hallum
Premium
The Fly
Akoya Biosciences price target lowered to $7 from $7.50 at Craig-Hallum
7M ago
Akoya Biosciences downgraded to Neutral from Buy at BTIG
Premium
The Fly
Akoya Biosciences downgraded to Neutral from Buy at BTIG
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100